Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yifan Biotechnology Group is a China-based comprehensive chemical manufacturer whose core business is agrochemicals rather than human biopharma. The group appears to operate across pesticide technicals, formulation processing, and sales, while also describing adjacent activities in pharmaceutical, veterinary, and industrial chemicals. Publicly available sources indicate the company was founded in 1992 and has multiple manufacturing plants, R&D laboratories, and sales entities in China, with an expanding international crop-protection business. In 2024, the group established Longwind Cropscience USA LLC to support commercialization of formulation products in the U.S. market. Based on available evidence, this is not primarily a life science or biotech therapeutics developer, and no human drug pipeline could be reliably identified.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yifan Biotechnology Group.